Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining and Predicting the Ideal Infliximab Pharmacokinetic Profile Associated With Treatment Efficacy in Patients With Inflammatory Bowel Disease

NCT01787786 is registered in ClinicalTrials.gov with University of Western Ontario, Canada as lead sponsor.

NCT NCT01787786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01787786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining and Predicting the Ideal Infliximab Pharmacokinetic Profile Associated With Treatment Efficacy in Patients With Inflammatory Bowel Disease
Lead sponsor
University of Western Ontario, Canada
Phase
Observational
Overall status
Withdrawn
Start date
Not reported
Completion date
September 30, 2017
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, ulcerative colitis